These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2733455)

  • 41. Remarkably long survival of a patient with Ph1-positive chronic myeloid leukemia and 5' bcr rearrangement.
    Johansson B; Mertens F; Fioretos T; Heim S; Kristoffersson U; Mandahl N; Bartram CR; Mitelman F
    Leukemia; 1990 Jun; 4(6):448-9. PubMed ID: 2359344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BCR rearrangement-negative chronic myelogenous leukemia revisited.
    Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
    J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease.
    Tien HF; Wang CH; Chen YC; Shen MC; Wu HS; Lee FY; Chuang SM; Liu CH
    Br J Haematol; 1990 Aug; 75(4):469-75. PubMed ID: 2206998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator.
    Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD
    Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
    Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
    Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The molecular pathology of chronic myelogenous leukaemia.
    Kurzrock R; Talpaz M
    Br J Haematol; 1991 Oct; 79 Suppl 1():34-7. PubMed ID: 1931706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes.
    Dubé I; Dixon J; Beckett T; Grossman A; Weinstein M; Benn P; McKeithan T; Norman C; Pinkerton P
    Genes Chromosomes Cancer; 1989 Sep; 1(1):106-11. PubMed ID: 2487142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
    Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
    Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular pathology of chronic myelogenous leukemia.
    Gorska-Flipot I; Norman C; Addy L; Minden M
    Tumour Biol; 1990; 11 Suppl 1():25-43. PubMed ID: 2247753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
    Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
    Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
    González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
    Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of proto-oncogene expression in the chronic and blastic phases of chronic myelogenous leukemia.
    Preisler HD; Agarwal R; Sato H; Singh PK; Wang ZQ; Sandberg AA
    Eur J Cancer; 1990; 26(9):960-5. PubMed ID: 2149022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
    J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
    Shtalrid M; Talpaz M; Blick M; Romero P; Kantarjian H; Taylor K; Trujillo J; Schachner J; Gutterman JU; Kurzrock R
    J Clin Oncol; 1988 Oct; 6(10):1569-75. PubMed ID: 3171624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts.
    Jiang XY; Trujillo JM; Dao D; Liang JC
    Cancer Genet Cytogenet; 1989 Oct; 42(2):287-94. PubMed ID: 2676142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.
    Guo JQ; Wang JY; Arlinghaus RB
    Cancer Res; 1991 Jun; 51(11):3048-51. PubMed ID: 2032243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
    Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
    Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
    De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
    Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.
    Montefusco E; Alimena G; Lo Coco F; De Cuia MR; Wang YZ; Aloe Spiriti MA; Mancini F; Cedrone M; Mancini M; Mandelli F
    Ann Hematol; 1992 Jul; 65(1):17-21. PubMed ID: 1643155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
    Martiat P; Michaux JL; Rodhain J
    Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.